CoChat

Systemic Steroid Treatment of Paradoxical Upgrading Reaction in Patients with Lymph Node Tuberculosis

Vidal, C. G., Garau, J. · 2005 · Clinical Infectious Diseases

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

Sir—We read with interest the article by Hawkey et al. [1]. They report that paradoxical upgrading reactions (PUR) to antituberculous treatment occurred in 23% of non—HIV-infected patients. This is the highest percentage ever reported in an immunocompetent population, in whom PUR is usually <5% [2, 3]. A plausible explanation is that the authors' definition of PUR includes worsening of tuberculosis in patients treated for only 10 days, and the presence of a discharging sinus and persistent lymphadenopathy. We think that a minimum of 4 weeks should elapse between the start of antituberculous therapy and the development of PUR because, by definition, an initial clinical improvement should take place before worsening [2–4]. Also, because a discharging sinus was a well-known complication of benign tuberculous lymph node disease in the preantibiotic era, it is difficult to justify as a defining symptom of PUR. These considerations are important in the analysis of the effect of corticosteroids in the treatment of PUR. In contrast with previous studies [2–5], Hawkey et al. [1] did not find any evidence of a beneficial effect and questioned the effectiveness of corticosteroids to treat PUR. We think that their analysis could be biased by their definition of PUR, by the different use of steroids depending upon the severity of disease, and by the difficulties involved in the follow-up of the evolution of PUR by means of medical charts. In our experience with patients with severe PUR to antituberculous treatment after exposure to infliximab, anti-inflammatory treatment played an important role [4]. In our cohort study, surgery to control PUR was required in all patients that did not receive anti-inflammatory agents. Conversely, no patient treated with anti-inflammatory drugs required surgery. Our results, and the well-known beneficial effects of corticosteroid therapy in reducing edema in intracranial tuberculomas [5–7], would suggest that severe PUR must be treated with steroids. Dosing and duration of treatment have not been defined; our limited experience would indicate that 4–6 weeks of oral steroids is adequate.

Overview

Integrity signals

Registry

Crossref · 10.1086/432807

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 12 references

Cited by

See all 24

Metadata

Authors
Vidal, C. G., & Garau, J.
Affiliations
University Hospital Mútua de Terrassa (ES)
Venue
Clinical Infectious Diseases
Published
2005-09-15
Volume
41
Issue
6
Pages
915-916
ISSN
  • 1058-4838 (ISSN-L)
  • 1537-6591
OpenAlex
W2063508336
Cited by
24
References
12
Citations by year
2023: 1 · 2022: 1 · 2021: 1 · 2020: 3 · 2019: 1 · 2017: 1 · 2016: 2 · 2015: 4 · 2014: 1 · 2013: 1 · 2012: 2
Type
journal article
Language
en
Open access
closed
Locations
  • Clinical Infectious Diseases (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
  • Health Sciences › Medicine › Infectious Diseases › Diagnosis and treatment of tuberculosis
  • Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
Keywords
tuberculous lymphadenitis, systemic corticosteroid therapy, infliximab, discharging sinuses, lymphadenopathy, surgical management, anti-inflammatory therapy
MeSH terms
Adrenal Cortex Hormones, Anti-Inflammatory Agents, Humans, Tuberculosis, Lymph Node

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Systemic Steroid Treatment of Paradoxical Upgrading Reaction in Patients with Lymph Node Tuberculosis. https://app.cochat.ai/papers/10.1086/432807
The paper
Vidal, C. G., & Garau, J. (2005). Systemic Steroid Treatment of Paradoxical Upgrading Reaction in Patients with Lymph Node Tuberculosis. Clinical Infectious Diseases. https://doi.org/10.1086/432807

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.